This compound is an Fmoc-protected, N-methylated amino acid derivative used as a building block in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) group for temporary protection of the amine during peptide chain assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 138775-22-1
Fmoc-N-methyl-L-valine
pharmaceutical intermediate
Fmoc-N-methyl-L-leucine
pharmaceutical intermediate
Fmoc-N-(2,4-dimethoxybenzyl)-Gly-OH
pharmaceutical intermediate
Fmoc-L-propargylglycine
pharmaceutical intermediate
3-[[(Acetylamino)methyl]thio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valine
pharmaceutical intermediate
Methyl 4-nitro-1H-pyrazole-3-carboxylate
pharmaceutical intermediate
Fmoc-O-tert-butyl-D-threonine
pharmaceutical intermediate
2-cyclopropyl-2-oxoacetic acid
pharmaceutical intermediate
(2S,3S)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylpentanoic acid
IQIOLCJHRZWOLS-XOBRGWDASA-N
CC[C@H](C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13